J-Pharma

NMD Pharma

This company develops small molecule therapies for patients suffering from severe neuromuscular disorders to restore skeletal muscle function.

j2hbio

This company develops small molecule pharmaceuticals and provides contract manufacturing services to global pharmaceutical partners to treat rare and incurable diseases.

Fundamental Pharma

This biopharmaceutical company develops small molecule inhibitors for patients suffering from treatment-resistant depression and neurodegenerative diseases such as amyotrophic lateral sclerosis.

BiPER Therapeutics

This company develops small molecule drugs targeting the BiP protein to treat gastrointestinal cancers and other pathological conditions in humans.

Noema Pharma

This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.

Enemsa Pharma

This company develops small-molecule neuroprotective therapies and combination drugs to treat patients with rare neurodegenerative and cardiopulmonary diseases.

Athira Pharma

This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.